STO:HNSA
Hansa Biopharma AB (publ) · STO · Healthcare · SEK · FY for 2025
Figures on this page computed 2026-11-08 02:32 UTC
Last close
n/aSEK
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-240.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
-247.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Price is the furthest below its sector's middle: 0.09 against 0.31 on the market's range.
- Growth105.3%83 of 100, above its sector
- Returns on capital-45.8%13 of 100, below its sector
- Margins62.4%27 of 100, below its sector
- Price14.4x9 of 100, below its sector
- Safety1.9432 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales3.02x
Its own average over 10 years, 73.5M.
- Profit1.15x
Its own average over 10 years, -464.9M.
- Free cash flow1.35x
Its own average over 10 years, -405.4M.
- Debt2.51x
Its own average over 10 years, 372.2M.
- Pricen/a
Its own average over 0 years. Market data
Sales is furthest from its own average, at 3.02 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2016-12-31 | 100.0 | 100.0 |
| 2017-12-31 | 133.5 | 107.9 |
| 2018-12-31 | 130.2 | 116.1 |
| 2019-12-31 | 130.4 | 121.2 |
| 2020-12-31 | 236.4 | 127.8 |
| 2021-12-31 | 1,313.6 | 134.7 |
| 2022-12-31 | 5,991.7 | 136.1 |
| 2023-12-31 | 5,199.5 | 159.2 |
| 2024-12-31 | 6,642.7 | 190.4 |
| 2025-12-31 | 8,618.3 | 246.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
Figures behind the shape
Growth
105.3%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate105.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
One-year change in net income33.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Returns on capital
-45.8%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equityn/mnegative equity
Negative equity.
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets-45.8%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
62.4%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin62.4%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin-234.3%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin-240.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-247.1%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
14.4xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
Price to bookn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio14.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.94safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.94
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score-4.92
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.